3. Respiratory system
3.11. Antifibrotics
Total Formulary
NINTEDANIB (OFEV) (capsules)
Restrictions:
Restricted to specialist use for the treatment of the following indications where an Interstitial Lung Disease Multidisciplinary Team has agreed it is appropriate:
- Idiopathic pulmonary fibrosis (IPF)
- Chronic fibrosing interstitial lung disease (ILDs) with a progressive phenotype other than idiopathic pulmonary fibrosis (IPF)
PIRFENIDONE (tablets)
Restrictions:
Restricted to specialist use only in patients with a predicted forced vital capacity (FVC) less than or equal to 80% where an Interstitial Lung Disease Multidisciplinary Team has agreed it is appropriate.